Cargando…
In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Massachusetts Medical Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730936/ https://www.ncbi.nlm.nih.gov/pubmed/36383452 http://dx.doi.org/10.1056/NEJMc2211845 |
_version_ | 1784845789512597504 |
---|---|
author | Takashita, Emi Yamayoshi, Seiya Halfmann, Peter Wilson, Nancy Ries, Hunter Richardson, Alex Bobholz, Max Vuyk, William Maddox, Robert Baker, David A. Friedrich, Thomas C. O’Connor, David H. Uraki, Ryuta Ito, Mutsumi Sakai-Tagawa, Yuko Adachi, Eisuke Saito, Makoto Koga, Michiko Tsutsumi, Takeya Iwatsuki-Horimoto, Kiyoko Kiso, Maki Yotsuyanagi, Hiroshi Watanabe, Shinji Hasegawa, Hideki Imai, Masaki Kawaoka, Yoshihiro |
author_facet | Takashita, Emi Yamayoshi, Seiya Halfmann, Peter Wilson, Nancy Ries, Hunter Richardson, Alex Bobholz, Max Vuyk, William Maddox, Robert Baker, David A. Friedrich, Thomas C. O’Connor, David H. Uraki, Ryuta Ito, Mutsumi Sakai-Tagawa, Yuko Adachi, Eisuke Saito, Makoto Koga, Michiko Tsutsumi, Takeya Iwatsuki-Horimoto, Kiyoko Kiso, Maki Yotsuyanagi, Hiroshi Watanabe, Shinji Hasegawa, Hideki Imai, Masaki Kawaoka, Yoshihiro |
author_sort | Takashita, Emi |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9730936 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Massachusetts Medical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-97309362022-12-09 In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6 Takashita, Emi Yamayoshi, Seiya Halfmann, Peter Wilson, Nancy Ries, Hunter Richardson, Alex Bobholz, Max Vuyk, William Maddox, Robert Baker, David A. Friedrich, Thomas C. O’Connor, David H. Uraki, Ryuta Ito, Mutsumi Sakai-Tagawa, Yuko Adachi, Eisuke Saito, Makoto Koga, Michiko Tsutsumi, Takeya Iwatsuki-Horimoto, Kiyoko Kiso, Maki Yotsuyanagi, Hiroshi Watanabe, Shinji Hasegawa, Hideki Imai, Masaki Kawaoka, Yoshihiro N Engl J Med Correspondence Massachusetts Medical Society 2022-11-16 /pmc/articles/PMC9730936/ /pubmed/36383452 http://dx.doi.org/10.1056/NEJMc2211845 Text en Copyright © 2022 Massachusetts Medical Society. All rights reserved. http://www.nejmgroup.org/legal/terms-of-use.htm This article is made available via the PMC Open Access Subset for unrestricted re-use, except commercial resale, and analyses in any form or by any means with acknowledgment of the original source. PMC is granted a license to make this article available via PMC and Europe PMC, subject to existing copyright protections. |
spellingShingle | Correspondence Takashita, Emi Yamayoshi, Seiya Halfmann, Peter Wilson, Nancy Ries, Hunter Richardson, Alex Bobholz, Max Vuyk, William Maddox, Robert Baker, David A. Friedrich, Thomas C. O’Connor, David H. Uraki, Ryuta Ito, Mutsumi Sakai-Tagawa, Yuko Adachi, Eisuke Saito, Makoto Koga, Michiko Tsutsumi, Takeya Iwatsuki-Horimoto, Kiyoko Kiso, Maki Yotsuyanagi, Hiroshi Watanabe, Shinji Hasegawa, Hideki Imai, Masaki Kawaoka, Yoshihiro In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6 |
title | In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6 |
title_full | In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6 |
title_fullStr | In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6 |
title_full_unstemmed | In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6 |
title_short | In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6 |
title_sort | in vitro efficacy of antiviral agents against omicron subvariant ba.4.6 |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730936/ https://www.ncbi.nlm.nih.gov/pubmed/36383452 http://dx.doi.org/10.1056/NEJMc2211845 |
work_keys_str_mv | AT takashitaemi invitroefficacyofantiviralagentsagainstomicronsubvariantba46 AT yamayoshiseiya invitroefficacyofantiviralagentsagainstomicronsubvariantba46 AT halfmannpeter invitroefficacyofantiviralagentsagainstomicronsubvariantba46 AT wilsonnancy invitroefficacyofantiviralagentsagainstomicronsubvariantba46 AT rieshunter invitroefficacyofantiviralagentsagainstomicronsubvariantba46 AT richardsonalex invitroefficacyofantiviralagentsagainstomicronsubvariantba46 AT bobholzmax invitroefficacyofantiviralagentsagainstomicronsubvariantba46 AT vuykwilliam invitroefficacyofantiviralagentsagainstomicronsubvariantba46 AT maddoxrobert invitroefficacyofantiviralagentsagainstomicronsubvariantba46 AT bakerdavida invitroefficacyofantiviralagentsagainstomicronsubvariantba46 AT friedrichthomasc invitroefficacyofantiviralagentsagainstomicronsubvariantba46 AT oconnordavidh invitroefficacyofantiviralagentsagainstomicronsubvariantba46 AT urakiryuta invitroefficacyofantiviralagentsagainstomicronsubvariantba46 AT itomutsumi invitroefficacyofantiviralagentsagainstomicronsubvariantba46 AT sakaitagawayuko invitroefficacyofantiviralagentsagainstomicronsubvariantba46 AT adachieisuke invitroefficacyofantiviralagentsagainstomicronsubvariantba46 AT saitomakoto invitroefficacyofantiviralagentsagainstomicronsubvariantba46 AT kogamichiko invitroefficacyofantiviralagentsagainstomicronsubvariantba46 AT tsutsumitakeya invitroefficacyofantiviralagentsagainstomicronsubvariantba46 AT iwatsukihorimotokiyoko invitroefficacyofantiviralagentsagainstomicronsubvariantba46 AT kisomaki invitroefficacyofantiviralagentsagainstomicronsubvariantba46 AT yotsuyanagihiroshi invitroefficacyofantiviralagentsagainstomicronsubvariantba46 AT watanabeshinji invitroefficacyofantiviralagentsagainstomicronsubvariantba46 AT hasegawahideki invitroefficacyofantiviralagentsagainstomicronsubvariantba46 AT imaimasaki invitroefficacyofantiviralagentsagainstomicronsubvariantba46 AT kawaokayoshihiro invitroefficacyofantiviralagentsagainstomicronsubvariantba46 |